Uganda: Come August, and Uganda will have one more problem to surmount amidst a host of crisis health issues-that of the receding stock of free antiretroviral. Soon, Uganda will be left with zilch options to help its people who are in the grips of disease.
The stock is said to be fast depleting in national referral hospitals. Many distribution set ups will not have enough to tide over the next couple of months. This is surely a sad twist to Uganda's AIDS campaign, and activists are extremely apprehensive of its fallout and the dire implication to lives.
Advertisement
Advertisement
Advertisement
|
Advertisement
Recommended Readings
Latest AIDS/HIV News
The Phase 1 trial for a preventive HIV vaccine candidate has initiated enrollment in both the United States and South Africa.
In the United States, African American women make up only 26% of female PrEP users, yet they account for 57% of new infections among women.
Scientists have made a groundbreaking discovery in the fight against HIV/AIDS with the successful resolution of the enigmatic immune-evading HIV protein complex.
Tailored quit-smoking programs are designed to address the risks associated with comorbidity in individuals living with HIV.
DNA editing tool CRISPR-Cas13 helps diagnose and signal the presence of HIV antibodies in HIV patients.
